ArcherDx Immunoverse

ArcherDx has launched Archer Immunoverse, a suite of immune repertoire sequencing assays. The targeted panels analyze RNA using Archer's patented Anchored Multiplex PCR (AMP) chemistry for open-ended amplification from molecular barcoded adaptors and next-generation sequencing to characterize the immune repertoire. After sequencing, the Immune Repertoire pipeline is used to identify clonotypes. The workflow requires less than 3.5 hours of hands-on time and between 25 nanograms and 2 micrograms of input RNA from peripheral blood mononuclear cells, formalin-fixed paraffin-embedded tissue, or fresh frozen tissue.